Penicillin: The Accidental Discovery

            The discovery of penicillin in 1928 by Sir Alexander Fleming marks one of the most pivotal moments in medical history. Before the antibiotic revolution, bacterial infections such as pneumonia, syphilis, and sepsis were frequently fatal (Adedeji, 2016). So much so that the average life expectancy before the 20th century was 47 years with fatality rates of bacterial infections between 30% to 40% and reaching higher percentages in the youth--compared to a 13.6% fatality rate from a study conducted by Lancet in 2019 (Ratner & Weiser, 2006; Ikuta et al., 2022). The accidental nature of this discovery emphasizes how scientific breakthroughs can result from unexpected and unanticipated observations, which can later be advanced and built upon through collaboration, innovation, perseverance, and necessity. The purpose of this paper is to discuss what penicillin is, how it was discovered, and its historical applications that eventually changed the world.

Figure 1

Penicillin Mold

Note. From How was penicillin developed?, by Science Museum, 2021 (url: https://www.sciencemuseum.org.uk/objects-and-stories/how-was-penicillin-developed)

What is Penicillin?

            Penicillin refers to a group of antibiotic medications derived from penicillin molds. These types of antibiotics consist of a beta-lactam ring that attaches to and disrupts the bacterial wall, leading to bacterial lysis and eventual destruction (The Cleveland Clinic, 2025). Penicillin is commonly used to treat a wide range of bacterial infections, including strep throat, syphilis, pneumonia, skin infections, and ear infections. Several types of penicillin have been observed and documented since the early 1900s: natural, semi-synthetic, and combination forms. Natural penicillins are effective against gram-positive and gram-negative organisms (i.e., bacteria with thick [gram-positive] or thin [gram-negative] peptidoglycan layer in their cell wall); however, a higher concentration of penicillin is required for the latter (Purdue Research Foundation, 1996). Semi-synthetic penicillin is modified to increase the effectiveness of the medication or to resist bacterial enzymes. Lastly, a combination penicillin pairs a penicillin derivative with another medication to counter its resistance to bacteria. These variations enable penicillin-based drugs to remain essential components of modern antimicrobial treatment.

Historical Significance of Penicillin

            Since the accidental discovery of penicillin in 1928, it has represented a transformative movement in medical history, shifting from an era of bacterial infections that were often fatal to one of adequate healthcare with antimicrobial remedies. Before the widespread use of penicillins, infectious diseases claimed millions of lives. They were often exacerbated by the lack of sanitary conditions (e.g., access to clean water) and limited treatment options for individuals (Lobanovska & Pilla, 2017). The success of penicillin as an effective, low-toxicity antibiotic demonstrated the potential of targeted antimicrobial therapies and shifted public health strategies toward prevention, intervention, and early treatment (Yip & Gerriets, 2024). The introduction of this antibiotic rapidly reduced mortality rates and transformed the life-threatening infections into manageable cures, thereby reshaping public trust in medical science, healthcare, and practitioners.

            The importance of penicillin became evident during World War II, when Allied forces extensively used it to treat wounds, prevent infections, and halt the spread of diseases among soldiers (Short, 2021). Between 1943 and 1944, the United States and allies scaled up the production and stockpiling of penicillin through joint scientific collaborations using large funding grants, enabling a mass distribution to military personnel to dramatically reduce bacterial-related infections and reduce the overall mortality rates as seen in previous conflicts (The American Chemical Society, 1999; Short, 2021). This dramatic increase in availability led to significantly reduced mortality rates among solders—during the Great War, between 12% and 15% of frontline soldiers died from infection, compared to a meaningful reduction to 3% in World War II—and contributed to the overall success of medical care (Cooter et al., 1998, as cited in Short, 2021).

            Beyond the battlefield, penicillin transformed the civilian healthcare industry by reducing maternal mortality, lowering death rates in childhood infections, while also becoming a staple in surgical prophylaxis. Its rapid adoption post-war represented a shift in global healthcare priorities, which emphasized preventative treatment for bacterial infections (Chhabra et al., 2024). Moreover, penicillin set the stage for the modern pharmaceutical industry by catalyzing the growth of industrial-scale drug production, which led to the subsequent discovery of new antibiotics. Governments and research institutions worldwide have begun to recognize the role of antibiotics in extending life expectancies and supporting the public's health. Designated as an "incalculable" lifesaver, penicillin remains a symbol of scientific progression and illustrates how inadvertent findings, curiosity, collaboration, and innovation can yield life-saving solutions to global challenges (Short, 2021).

The Accidental Discovery of Penicillin

The origin of penicillin is often cited as a classic case of serendipity in science. In 1928, Sir Alexander Fleming—a bacteriologist and researcher at St. Mary's Hospital in London, England—returned from vacation to find that a petri dish containing Staphylococcus aureus had been contaminated by mold (Gaynes, 2017). However, the area surrounding the mold was clear of bacteria, which indicated a substance with antibacterial properties. Fleming identified the mold as belonging to the genus of Penicillium and named the active compound "penicillin." Despite publishing his findings to the Medical Research Club in 1929, Fleming's research received little interest from his peers. Challenges in purifying penicillin for production further obscured its potential, leading Fleming to regard the discovery as merely a laboratory curiosity (Science Museum, 2021).

            In 1939, a decade after Fleming published his findings, a team from the University of Oxford, including Howard Florey and Ernst Shain, with significant contributions from Norman Heatley, began work on isolating penicillin for mass production. By 1940, the Oxford team had confirmed the efficacy of penicillin through animal testing on laboratory mice. However, they noted that "humans are roughly 3000 times bigger and would need 3000 times more penicillin" (University of Oxford, 2010). In February 1941, the Oxford team produced enough penicillin to begin human trials, which were an enormous success. The challenge of large-scale production led the Oxford team to the United States, where a collaboration with the U.S. Department of Agriculture's research laboratory began. Using deep fermentation tanks and other products (e.g., corn steep liquor), their efforts paid off; however, pharmaceutical companies were reluctant to commit to large-scale penicillin production (Science Museum, 2021). After the United States entered World War II in 1941, the demand for penicillin surged dramatically, prompting pharmaceutical companies to begin mass-producing the "miracle drug" to support the war effort. This breakthrough not only fueled the growth of the pharmaceutical industry but also contributed to a reduction in morbidity and spurred advancements in other areas of medicine. Nevertheless, as early as Fleming's 1945 Nobel Prize speech, Fleming warned of the dangers of improper dosing and overuse, stressing that bacterial resistance could become a serious global health threat, highlighting the ongoing need for innovation and responsible antibiotic stewardship (Magalhaes et al., 2021).

Social and Economic Forces Affecting Penicillin in Pre- and Post-War Eras

            The rapid advancement and widespread adoption of penicillin were significantly influenced by the societal context of the time, particularly the demands of World War II. The urgent need to treat battlefield infections compelled production, investment, and research into antibiotics. Public pressure and the moral imperative to save soldiers' lives led to an alignment between scientific, military, and industrial efforts to accelerate the large-scale production of penicillin, which in turn fostered breakthroughs in the fermentation and engineering of microorganisms (Science Museum, 2021). This collaborative mobilization not only addressed wartime needs but also laid the foundation for a healthcare infrastructure more responsive to scientific innovation. However, the growing societal expectation that antibiotics could offer a universal cure fostered a culture of overreliance. As penicillin became widely available, the demand for antibiotic prescriptions surged, contributing to patterns, as forewarned by Fleming, of misuse that would later accelerate the development of bacterial resistance and necessitate continued innovation in the field to produce effective medicines.

            Economically, private industry recognized penicillin as a profitable, commercial antibiotic that could help expand their infrastructure, research capacity, and manufacturing capabilities. Following the war, the demand for penicillin among the civilian population increased as the antibiotic became essential for treating common infections. The transition from a life-saving military necessity to a commercial staple ensured the long-term market viability and positioned antibiotics as a cornerstone of modern medicine. Yet, this economic success also introduces significant challenges. Market compensation encouraged mass production and aggressive marketing, sometimes at the expense of sensible medical practice (Morel et al., 2020). The commodification of antibiotics reinforced a volume-driven model of healthcare, where societal access often came without sufficient education on proper use. These dynamics underscore the dual-edged nature of penicillin's legacy, where triumphant collaboration and innovation are met with a cautionary tale of unintended consequences if left unchecked and unmonitored.

Conclusion

            The discovery and development of penicillin stand as a defining, accidental achievement that not only transformed the treatment of infectious diseases but also reshaped global healthcare systems, pharmaceutical industries, and scientific research paradigms. The impact of penicillin during World War II demonstrated how social urgency and economic mobilization could rapidly accelerate scientific innovation, while its post-war integration into civilian life underscored its therapeutic and economic value. However, penicillin's legacy is also marked with caution, as the societal and commercial pressures that fueled its rise also contributed to antibiotic overuse and the emergence of bacterial resistance. As a result, penicillin remains both a symbol of groundbreaking progress and a reminder of the importance of responsible medical practice, regulatory oversight, and sustainable research. The story continues to inform present-day efforts in antimicrobial stewardship and the pursuit of next-generation treatments in a world battling adaptable infectious diseases.

 

References

Adedeji, W. A. (2016, December 14). The treasure called antibiotics. Retrieved July 02, 2025, from www.pmc.ncbi.nlm.nih.gov: https://pmc.ncbi.nlm.nih.gov/articles/PMC5354621/

Chhabra, S., Taksande, A. B., & Munjewar, P. (2024, July 23). The penicillin pioneer: Alexander fleming's journey to a medical breakthrough. doi:10.7759/cureus.65179

Cooter, R., Harrison, M., & Sturdy, S. (1998). Neushul fighting research: Army participation in the clinical testing and mass production of penicillin during the second world war. War, Medicine and Modernity, 203-224. Retrieved July 06, 2025, from https://search.worldcat.org/title/War-medicine-and-modernity/oclc/1424869576

Gaynes, R. (2017, May 23). The discovery of penicillin: New insights after more than 75 years of clinical use. doi:10.3201/eid2305.161556

Ikuta et al. (2022, December 17). Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the global burden of disease study 2019. GBD 2019 Antimicrobial Resistance Collaborators, 400(10369), 2221-2248. doi:10.1016/S0140-6736(22)02185-7

Lobanovska, M., & Pilla, G. (2017, March 29). Penicillin's discovery and antibiotic resistance: Lessons for the future? Retrieved July 06, 2025, from www.pmc.ncbi.nlm.nih.gov: https://pmc.ncbi.nlm.nih.gov/articles/PMC5369031/

Magalhaes, C., Lima, M., Trieu-Cuot, P., & Ferreira, P. (2021, July). To give or not to give antibiotics is not the only question. The lancet infectious diseases, 21(7), 191-201. doi:10.1016/S1473-3099(20)30602-2

Morel, C. M., Lindahl, O., Harbarth, S., Kraker, M. E., Edwards, S., & Hollis, A. (2020). Industry incentives and antibiotic resistance: An introduction to the antibiotic susceptibility bonus. The Journal of Antibiotics, 73, 421-428. doi:10.1038/s41429-020-0300-y

Purdue Research Foundation. (1996). Penicillin Derivatives. Retrieved July 02, 2025, from www.cyto.purdue.edu: http://www.cyto.purdue.edu/cdroms/cyto2/17/chmrx/penems.htm

Ratner, A. J., & Weiser, J. N. (2006, September 01). Pneumonia before antibiotics: Therapeutic evolution and evaluation in twentieth-century america. doi:10.1172/JCI29920

Science Museum. (2021, February 23). How was penicillin developed? Retrieved July 06, 2025, from www.sciencemuseum.org.uk: https://www.sciencemuseum.org.uk/objects-and-stories/how-was-penicillin-developed

Short, B. (2021, September). Antibacterial warfare: The production of natural penicillin and the search for synthetic penicillin during the second world war. Journal of Military and Veterans' Health, 29(3). doi:09.2021-14945335/JMVH Vol 29 No 3

The American Chemical Society. (1999, November 19). The discovery and development of penicillin. Retrieved July 06, 2025, from www.acs.org: https://www.acs.org/content/dam/acsorg/education/whatischemistry/landmarks/flemingpenicillin/the-discovery-and-development-of-penicillin-commemorative-booklet.pdf

The Cleveland Clinic. (2025). Penicillin. Retrieved July 02, 2025, from www.my.clevelandclinic.org: https://my.clevelandclinic.org/health/treatments/penicillin#overview

University of Oxford. (2010, July 16). Penicillin: The oxford story. Retrieved July 06, 2025, from www.ox.ac.uk: https://www.ox.ac.uk/news/science-blog/penicillin-oxford-story

Yip, D. W., & Gerriets, V. (2024, February 20). Penicillin. Retrieved July 06, 2025, from www.ncbi.nlm.nih.gov: https://www.ncbi.nlm.nih.gov/books/NBK554560/